Al's Comment:

 Most of the funds used for these grants were raised by our National Walks To End Brain Tumors. We had an actual live 5k walk in Florida and a virtual walk in MN. We have 2 virtual walks coming up in NJ and another in UT. See for details. A special thanks to those volunteers and participants who made this possible!

For the grant from our DIPG All-in-initiative fund, some of the funding came from our partners in the DIPG All-In-Initative:  The McKenna Claire Foundation and the Prayers From Maria Foundation. 


Posted on: 05/23/2021

Musella Foundation awards three brain tumor research grants!


Hewlett, NY 5/23/2021 - The Musella Foundation is pleased to announce that we have awarded three more  brain tumor research grants in the total amount of $72,000.  
The projects:
$50,000 grant to Maria Trissal, MD PhD of the Dana-Farber Cancer Institute for the project:  "Identifying the Effect of PDGFRA inhibition on H3K27M Diffuse Midline Gliomas (DMGs)". This is from our DIPG All-In-Initiative fund.
$12,000 to  Dr. Madan Kwatra of Duke University  for the project: Generating patient derived gliomas within Cerebral Organoids to be Treated with Repurposed drugs       
$10,000 to the Central Brain Tumor Registry of the United States for the project titled: "Provision of the most current population-based statistical information for all primary brain and other central nervous system (CNS) tumors in the United States".  This is our annual grant to help support this important ongoing project.
About the Musella Foundation 
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy, emotional and financial support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease. Our patient navigation program is unlike any other such program – a team of experts evaluate each case, and we track the outcomes so we learn from every patient.


Click HERE to return to brain tumor news headlines.